Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial. Yoshioka T, Takahashi M, Sakamoto Y, Okita A, et al. Anticancer Res 2022;42:2009-2015.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yoshioka T, Takahashi M, Sakamoto Y, Okita A, et al. Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial. Anticancer Res 2022;42:2009-2015.
PMID: 35347022